Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01290432 · ClinicalTrials.gov registry record · NA

The Potential Effects of Inofolic Plus on Abnormal Ovarian Reserve Parameters in Subfertile Women

A NA study of Infertility, Female, sponsored by Palm Beach Center for Reproductive Medicine.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT01290432: Completed NA study of Infertility, Female, sponsored by Palm Beach Center for Reproductive Medicine.

NCT01290432 is a NA study of Infertility, Female that has completed, run by Palm Beach Center for Reproductive Medicine. The registered enrollment target is 15 participants, below the 382-participant average among 18 other Infertility, Female trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01290432, a NA study of Infertility, Female, has completed, sponsored by Palm Beach Center for Reproductive Medicine.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

Dr. Roseff and his colleagues are conducting a study to evaluate the effectiveness of a novel substance (Inofolic Plus®) in improving oocyte (egg) parameters in subfertile female patients, as measured through Anti-Mullerian Hormone (AMH) blood levels.

Primary Outcome

Women will receive Infolic Plus nightly for up to 90 days. Baseline AMH blood levels will be analyzed, and AMH titers will be checked monthly thereafter for the 90 day duration of the study.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Inofolic Plus

Study Locations (1)

Florida

  • Palm Beach Center for Reproductive Medicine - Wellington

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2011-02
Est. Completion 2012-02
Phase NA

What the finished NCT01290432 record still lists

NCT01290432 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 382-participant average among 18 other Infertility, Female trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Infertility, Female appearing as the primary indexed condition, and to 1 intervention - of which Inofolic Plus is the first listed.

NCT01290432 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT01290432 about?

NCT01290432 is a clinical study titled "The Potential Effects of Inofolic Plus on Abnormal Ovarian Reserve Parameters in Subfertile Women". Dr. Roseff and his colleagues are conducting a study to evaluate the effectiveness of a novel substance (Inofolic Plus®) in improving oocyte (egg) parameters in subfertile female patients, as measured through Anti-Mullerian Hormone (AMH) blood levels.

What is the current status of trial NCT01290432?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2011-02. Estimated completion is 2012-02.

What conditions does trial NCT01290432 study?

This clinical trial studies the following conditions: Infertility, Female.

What interventions are being tested in trial NCT01290432?

The interventions under investigation include: Inofolic Plus (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01290432?

This trial is sponsored by Palm Beach Center for Reproductive Medicine, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01290432 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility, Female

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01290432's enrollment target sits among peer trials

15 18th of 18 higher than 1 of 18 other Infertility, Female trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infertility, Female trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01290432, the US trial registry maintained by the National Library of Medicine. NCT01290432 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.